메뉴 건너뛰기




Volumn 27, Issue 32, 2009, Pages 4320-4324

The co-administration of CpG-ODN influenced protective activity of influenza M2e vaccine

Author keywords

CpG ODN; Influenza virus; M2e; Protective activity; Th1 response

Indexed keywords

CPG OLIGODEOXYNUCLEOTIDE; GAMMA INTERFERON; IMMUNOGLOBULIN G2A; INFLUENZA M2E VACCINE; INFLUENZA VACCINE; UNCLASSIFIED DRUG;

EID: 67649479249     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2009.04.075     Document Type: Article
Times cited : (44)

References (19)
  • 1
    • 30444444679 scopus 로고    scopus 로고
    • Development of effective vaccines against pandemic influenza
    • Subbarao K., Murphy B.R., and Fauci A.S. Development of effective vaccines against pandemic influenza. Immunity 24 1 (2006) 5-9
    • (2006) Immunity , vol.24 , Issue.1 , pp. 5-9
    • Subbarao, K.1    Murphy, B.R.2    Fauci, A.S.3
  • 2
    • 0025241767 scopus 로고
    • Passively transferred monoclonal antibody to the M2 protein inhibits influenza A virus replication in mice
    • Treanor J.J., Tierney E.L., Zebedee S.L., Lamb R.A., and Murphy B.R. Passively transferred monoclonal antibody to the M2 protein inhibits influenza A virus replication in mice. J Virol 64 3 (1990) 1375-1377
    • (1990) J Virol , vol.64 , Issue.3 , pp. 1375-1377
    • Treanor, J.J.1    Tierney, E.L.2    Zebedee, S.L.3    Lamb, R.A.4    Murphy, B.R.5
  • 3
    • 0032874490 scopus 로고    scopus 로고
    • A universal influenza A vaccine based on the extracellular domain of the M2 protein
    • Neirynck S., Deroo T., Saelens X., Vanlandschoot P., Jou W.M., and Fiers W. A universal influenza A vaccine based on the extracellular domain of the M2 protein. Nat Med 5 10 (1999) 1157-1163
    • (1999) Nat Med , vol.5 , Issue.10 , pp. 1157-1163
    • Neirynck, S.1    Deroo, T.2    Saelens, X.3    Vanlandschoot, P.4    Jou, W.M.5    Fiers, W.6
  • 4
    • 2442671345 scopus 로고    scopus 로고
    • Monoclonal antibodies recognizing EVETPIRN epitope of influenza A virus M2 protein could protect mice from lethal influenza A virus challenge
    • Liu W., Zou P., and Chen Y.H. Monoclonal antibodies recognizing EVETPIRN epitope of influenza A virus M2 protein could protect mice from lethal influenza A virus challenge. Immunol Lett 93 2-3 (2004) 131-136
    • (2004) Immunol Lett , vol.93 , Issue.2-3 , pp. 131-136
    • Liu, W.1    Zou, P.2    Chen, Y.H.3
  • 5
    • 0028821987 scopus 로고
    • Protection of mice against influenza A virus challenge by vaccination with baculovirus-expressed M2 protein
    • Slepushkin V.A., Katz J.M., Black R.A., Gamble W.C., Rota P.A., and Cox N.J. Protection of mice against influenza A virus challenge by vaccination with baculovirus-expressed M2 protein. Vaccine 13 15 (1995) 1399-1402
    • (1995) Vaccine , vol.13 , Issue.15 , pp. 1399-1402
    • Slepushkin, V.A.1    Katz, J.M.2    Black, R.A.3    Gamble, W.C.4    Rota, P.A.5    Cox, N.J.6
  • 6
    • 0036330730 scopus 로고    scopus 로고
    • Vaccination of pigs with a DNA construct expressing an influenza virus M2-nucleoprotein fusion protein exacerbates disease after challenge with influenza A virus
    • Heinen P.P., Rijsewijk F.A., de Boer-Luijtze E.A., and Bianchi A.T. Vaccination of pigs with a DNA construct expressing an influenza virus M2-nucleoprotein fusion protein exacerbates disease after challenge with influenza A virus. J Gen Virol 83 Pt 8 (2002) 1851-1859
    • (2002) J Gen Virol , vol.83 , Issue.PART 8 , pp. 1851-1859
    • Heinen, P.P.1    Rijsewijk, F.A.2    de Boer-Luijtze, E.A.3    Bianchi, A.T.4
  • 7
    • 36749090029 scopus 로고    scopus 로고
    • Characterization of immunity induced by M2e of influenza virus
    • Wu F., Huang J.H., Yuan X.Y., Huang W.S., and Chen Y.H. Characterization of immunity induced by M2e of influenza virus. Vaccine 25 52 (2007) 8868-8873
    • (2007) Vaccine , vol.25 , Issue.52 , pp. 8868-8873
    • Wu, F.1    Huang, J.H.2    Yuan, X.Y.3    Huang, W.S.4    Chen, Y.H.5
  • 8
    • 67649529544 scopus 로고    scopus 로고
    • Heterosubtypic protection conferred by combined vaccination with M2e peptide and split influenza vaccine
    • Wu F., Yuan X.Y., Huang W.S., and Chen Y.H. Heterosubtypic protection conferred by combined vaccination with M2e peptide and split influenza vaccine. Vaccine (2008)
    • (2008) Vaccine
    • Wu, F.1    Yuan, X.Y.2    Huang, W.S.3    Chen, Y.H.4
  • 9
    • 2942549527 scopus 로고    scopus 로고
    • Use of CpG oligodeoxynucleotides as immune adjuvants
    • Klinman D.M., Currie D., Gursel I., and Verthelyi D. Use of CpG oligodeoxynucleotides as immune adjuvants. Immunol Rev 199 (2004) 201-216
    • (2004) Immunol Rev , vol.199 , pp. 201-216
    • Klinman, D.M.1    Currie, D.2    Gursel, I.3    Verthelyi, D.4
  • 10
    • 0031964257 scopus 로고    scopus 로고
    • CpG DNA is a potent enhancer of specific immunity in mice immunized with recombinant hepatitis B surface antigen
    • Davis H.L., Weeratna R., Waldschmidt T.J., Tygrett L., Schorr J., and Krieg A.M. CpG DNA is a potent enhancer of specific immunity in mice immunized with recombinant hepatitis B surface antigen. J Immunol 160 2 (1998) 870-876
    • (1998) J Immunol , vol.160 , Issue.2 , pp. 870-876
    • Davis, H.L.1    Weeratna, R.2    Waldschmidt, T.J.3    Tygrett, L.4    Schorr, J.5    Krieg, A.M.6
  • 11
    • 33646847166 scopus 로고    scopus 로고
    • Protection capability of recombinant plasmid DNA vaccine containing VP2 gene of very virulent infectious bursal disease virus in chickens adjuvanted with CpG oligodeoxynucleotide
    • Mahmood M.S., Siddique M., Hussain I., Khan A., and Mansoor M.K. Protection capability of recombinant plasmid DNA vaccine containing VP2 gene of very virulent infectious bursal disease virus in chickens adjuvanted with CpG oligodeoxynucleotide. Vaccine 24 22 (2006) 4838-4846
    • (2006) Vaccine , vol.24 , Issue.22 , pp. 4838-4846
    • Mahmood, M.S.1    Siddique, M.2    Hussain, I.3    Khan, A.4    Mansoor, M.K.5
  • 12
    • 35148818470 scopus 로고    scopus 로고
    • DNA vaccination with VP2 gene of very virulent infectious bursal disease virus (vvIBDV) delivered by transgenic E. coli DH5alpha given orally confers protective immune responses in chickens
    • Mahmood M.S., Hussain I., Siddique M., Akhtar M., and Ali S. DNA vaccination with VP2 gene of very virulent infectious bursal disease virus (vvIBDV) delivered by transgenic E. coli DH5alpha given orally confers protective immune responses in chickens. Vaccine 25 44 (2007) 7629-7635
    • (2007) Vaccine , vol.25 , Issue.44 , pp. 7629-7635
    • Mahmood, M.S.1    Hussain, I.2    Siddique, M.3    Akhtar, M.4    Ali, S.5
  • 13
    • 0035825599 scopus 로고    scopus 로고
    • Oligonucleotide containing CpG motifs enhances immune response to mucosally or systemically administered tetanus toxoid
    • Eastcott J.W., Holmberg C.J., Dewhirst F.E., Esch T.R., Smith D.J., and Taubman M.A. Oligonucleotide containing CpG motifs enhances immune response to mucosally or systemically administered tetanus toxoid. Vaccine 19 13-14 (2001) 1636-1642
    • (2001) Vaccine , vol.19 , Issue.13-14 , pp. 1636-1642
    • Eastcott, J.W.1    Holmberg, C.J.2    Dewhirst, F.E.3    Esch, T.R.4    Smith, D.J.5    Taubman, M.A.6
  • 14
    • 0031800888 scopus 로고    scopus 로고
    • CpG DNA, a novel immune enhancer for systemic and mucosal immunization with influenza virus
    • Moldoveanu Z., Love-Homan L., Huang W.Q., and Krieg A.M. CpG DNA, a novel immune enhancer for systemic and mucosal immunization with influenza virus. Vaccine 16 11-12 (1998) 1216-1224
    • (1998) Vaccine , vol.16 , Issue.11-12 , pp. 1216-1224
    • Moldoveanu, Z.1    Love-Homan, L.2    Huang, W.Q.3    Krieg, A.M.4
  • 16
    • 0032738026 scopus 로고    scopus 로고
    • Advances in vaccine adjuvants
    • Singh M., and O'Hagan D. Advances in vaccine adjuvants. Nat Biotechnol 17 11 (1999) 1075-1081
    • (1999) Nat Biotechnol , vol.17 , Issue.11 , pp. 1075-1081
    • Singh, M.1    O'Hagan, D.2
  • 17
    • 0036644485 scopus 로고    scopus 로고
    • Type I IFN as a natural adjuvant for a protective immune response: lessons from the influenza vaccine model
    • Proietti E., Bracci L., Puzelli S., Di Pucchio T., Sestili P., De Vincenzi E., et al. Type I IFN as a natural adjuvant for a protective immune response: lessons from the influenza vaccine model. J Immunol 169 1 (2002) 375-383
    • (2002) J Immunol , vol.169 , Issue.1 , pp. 375-383
    • Proietti, E.1    Bracci, L.2    Puzelli, S.3    Di Pucchio, T.4    Sestili, P.5    De Vincenzi, E.6
  • 18
    • 0034177875 scopus 로고    scopus 로고
    • Neonatal administration of IL-12 enhances the protective efficacy of antiviral vaccines
    • Arulanandam B.P., Mittler J.N., Lee W.T., O'Toole M., and Metzger D.W. Neonatal administration of IL-12 enhances the protective efficacy of antiviral vaccines. J Immunol 164 7 (2000) 3698-3704
    • (2000) J Immunol , vol.164 , Issue.7 , pp. 3698-3704
    • Arulanandam, B.P.1    Mittler, J.N.2    Lee, W.T.3    O'Toole, M.4    Metzger, D.W.5
  • 19
    • 2142810269 scopus 로고    scopus 로고
    • Influenza A vaccine based on the extracellular domain of M2: weak protection mediated via antibody-dependent NK cell activity
    • Jegerlehner A., Schmitz N., Storni T., and Bachmann M.F. Influenza A vaccine based on the extracellular domain of M2: weak protection mediated via antibody-dependent NK cell activity. J Immunol 172 9 (2004) 5598-5605
    • (2004) J Immunol , vol.172 , Issue.9 , pp. 5598-5605
    • Jegerlehner, A.1    Schmitz, N.2    Storni, T.3    Bachmann, M.F.4


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.